Lisa A. Michaels
Bayer (United States)(US)
Publications by Year
Research Areas
Blood Coagulation and Thrombosis Mechanisms, Hemophilia Treatment and Research, Venous Thromboembolism Diagnosis and Management, Platelet Disorders and Treatments, Hemoglobinopathies and Related Disorders
Most-Cited Works
- → A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the intercontinental childhood ITP study group(2003)285 cited
- → Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group(2011)155 cited
- → Age and the Prevalence of Bleeding Disorders in Women With Menorrhagia(2005)149 cited
- → Phase I study of BAY 94‐9027, a PEGylated B‐domain‐deleted recombinant factor VIII with an extended half‐life, in subjects with hemophilia A(2014)143 cited
- → Safety and efficacy of BAY 94‐9027, a prolonged‐half‐life factor VIII(2016)116 cited
- → PEGylated therapeutic proteins for haemophilia treatment: a review for haemophilia caregivers(2012)104 cited
- → Low Molecular Weight Heparin in the Treatment of Venous and Arterial Thromboses in the Premature Infant(2004)97 cited
- → Prophylaxis in congenital factor VII deficiency: indications, efficacy and safety. Results from the Seven Treatment Evaluation Registry (STER)(2013)92 cited
- → Serum Levels of Substance P Are Elevated in Patients With Sickle Cell Disease and Increase Further During Vaso-Occlusive Crisis(1998)87 cited
- → Screening for hereditary spherocytosis by use of automated erythrocyte indexes(1997)69 cited